Advanced cholangiocarcinoma
Clinical trials for Advanced cholangiocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Advanced cholangiocarcinoma trials appear
Sign up with your email to follow new studies for Advanced cholangiocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug AU409 enters first human trial for tough liver cancers
Disease control PausedThis early-stage trial tests a new drug called AU409 in 36 people with advanced liver cancers or solid tumors that have spread to the liver. The main goals are to find the safest dose and check for side effects. Researchers will also look for signs that the drug might shrink tumo…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase 1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hope for bile duct cancer patients: expanded access to targeted drug futibatinib
Disease control ApprovedThis program provides futibatinib (TAS-120) to adults with advanced bile duct cancer that has a specific FGFR2 gene change and who have no other treatment options. Participants take one 20 mg pill daily. The goal is to give access to this drug while it is being studied further.
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC